RMD

Is This the Right Time to Retain Resmed Stock in Your Portfolio?

A Look at ResMed Inc (RMD) After 4.2% Gain -- GF Value $271.26 vs Price $194.32

Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million

ResMed Inc. (RMD) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript

Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio

ResMed (RMD) is a Top-Ranked Growth Stock: Should You Buy?

The Hidden 401(k) Tax Bomb That Hits a $1.3 Million Saver With $19,800 in Their First RMD Year